Simplex Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,162
| Closed | -$9K | – | 10046 |
|
|
2024
Q4 | $9K | Buy |
18,162
+9,807
| +117% | +$27.9K | ﹤0.01% | 7295 |
|
|
2024
Q3 | $31K | Buy |
+8,355
| New | +$39.9K | ﹤0.01% | 6340 |
|
|
2024
Q1 | – | Sell |
-28,949
| Closed | -$159K | – | 10175 |
|
|
2023
Q4 | $151K | Buy |
28,949
+28,719
| +12,487% | +$284K | ﹤0.01% | 4973 |
|
|
2023
Q3 | $3K | Buy |
+230
| New | +$4.13K | ﹤0.01% | 7998 |
|
|
2020
Q4 | – | Sell |
-1,410
| Closed | -$59K | – | 9238 |
|
|
2020
Q3 | $59K | Sell |
1,410
-2,319
| -62% | -$101K | ﹤0.01% | 5453 |
|
|
2020
Q2 | $178K | Sell |
3,729
-18,528
| -83% | -$924K | ﹤0.01% | 4122 |
|
|
2020
Q1 | $1.02M | Buy |
+22,257
| New | +$1.12M | ﹤0.01% | 1861 |
|
|
2019
Q1 | – | Sell |
-23,341
| Closed | -$1.04M | – | 8039 |
|
|
2018
Q4 | $940K | Buy |
23,341
+20,966
| +883% | +$1.08M | ﹤0.01% | 1686 |
|
|
2018
Q3 | $164K | Buy |
+2,375
| New | +$180K | ﹤0.01% | 3880 |
|
|
2018
Q2 | – | Sell |
-2,348
| Closed | -$148K | – | 8003 |
|
|
2018
Q1 | $123K | Sell |
2,348
-3,482
| -60% | -$202K | 0.01% | 1636 |
|
|
2017
Q4 | $311K | Buy |
5,830
+3,149
| +117% | +$175K | 0.01% | 971 |
|
|
2017
Q3 | $159K | Buy |
+2,681
| New | +$162K | 0.01% | 1355 |
|
|
2017
Q1 | – | Sell |
-672
| Closed | -$50K | – | 6916 |
|
|
2016
Q4 | $53K | Buy |
+672
| New | +$48.8K | ﹤0.01% | 2102 |
|
|
2016
Q2 | – | Sell |
-2,351
| Closed | -$97.9K | – | 6584 |
|
|
2016
Q1 | $95K | Sell |
2,351
-3,386
| -59% | -$215K | 0.01% | 1404 |
|
|
2015
Q4 | $508K | Buy |
+5,737
| New | +$453K | 0.04% | 425 |
|
|
2015
Q3 | – | Sell |
-4,495
| Closed | -$374K | – | 6327 |
|
|
2015
Q2 | $363K | Buy |
+4,495
| New | +$293K | 0.03% | 497 |
|
Other funds holding EGRX
Simplex Trading's EGRX Position: Q1 2025 in Review
Simplex Trading sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2025, closing a stake of 18,162 shares — an estimated $9K sold.
Simplex Trading first reported a position in EGRX in Q2 2015 and held it in 16 quarters. The position peaked at $1.02M in Q1 2020. 2 funds tracked by Wall St. Rank hold EGRX as of Q1 2025.
- Simplex Trading reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 18,162 Eagle Pharmaceuticals, Inc. shares in Q1 2025, an estimated $9K.
- Simplex Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
- Simplex Trading's Eagle Pharmaceuticals, Inc. position peaked at $1.02M in Q1 2020.
- 2 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.